AEON Biopharma, Inc.
AEON- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001837607
In the last 90 days, AEON Biopharma, Inc. insiders filed 1 open-market purchase and 0 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $9.22M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding AEON Biopharma, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 47 | 59 | +12 |
| Shares | 13.1M | 17.6M | +4.55M (+34.8%) |
| Value | $126.0M | $171.8M | +$45.8M (+36.3%) |
New holders (14)
Institutions that held AEON Biopharma, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Empyrean Capital Partners, LP | 1,400,000 | $13.6M | 0.32% |
| HSBC Holdings PLC | 899,900 | $8.77M | 0.01% |
| Shaolin Capital Management LLC | 809,943 | $7.89M | 0.24% |
| CSS LLC | 335,000 | $3.26M | 0.17% |
| Arena Capital Advisors, LLC- CA | 249,600 | $2.43M | 0.19% |
| State of Wisconsin Investment Board | 160,000 | $1.56M | 0.00% |
| Echo Street Capital Management LLC | 100,000 | $975.0K | 0.01% |
| Segantii Capital Management Ltd | 50,000 | $488.0K | 0.02% |
| Highland Capital Management Fund Advisors, L.P. | 41,155 | $401.0K | 0.07% |
| Rivernorth Capital Management, LLC | 39,996 | $390.0K | 0.02% |
| Berkley W R Corp | 25,088 | $244.0K | 0.02% |
| Robinson Capital Management, LLC | 10,408 | $101.0K | 0.09% |
| Toroso Investments, LLC | 10,408 | $101.0K | 0.00% |
| 683 Capital Management, LLC | 9,999 | $97.0K | 0.01% |
Sold out (2)
Institutions that held AEON Biopharma, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Verition Fund Management LLC | 299,900 | $2.89M |
| Panagora Asset Management Inc | 792 | $8.00K |